{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T01:12:58Z","timestamp":1759799578643,"version":"build-2065373602"},"reference-count":60,"publisher":"Georg Thieme Verlag KG","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pneumologie"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Allgemeine Therapiema\u00dfnahmen und besondere Situationen wurden bei der 7.\u2006Weltkonferenz f\u00fcr Pulmonale Hypertonie von der neunten Taskforce bearbeitet. Sie konzentrierte sich v.\u200aa. auf die Patient*innenperspektive, allgemeine und supportive Ma\u00dfnahmen und bei Patient*innen bestehende herausfordernde Bedingungen. Bei letzteren werden insbesondere die perioperative Versorgung, das Management w\u00e4hrend der Schwangerschaft, Medikamentenadh\u00e4renz, Palliativversorgung und der Einfluss des Klimas auf die Erkrankung beleuchtet. Dar\u00fcber hinaus werden in dieser Arbeit einige Themen zus\u00e4tzlich angesprochen, die in diesen Kontext fallen, jedoch nicht bei der Weltkonferenz Ber\u00fccksichtigung fanden, wie z.\u200aB. Ern\u00e4hrung bei pulmonaler Hypertonie, Reisen und Einsatz kardiovaskul\u00e4rer Medikamente.<\/jats:p>","DOI":"10.1055\/a-2625-4859","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:42:36Z","timestamp":1759790556000},"page":"762-774","source":"Crossref","is-referenced-by-count":0,"title":["Allgemeine Ma\u00dfnahmen und Management der PAH in besonderen Situationen"],"prefix":"10.1055","volume":"79","author":[{"given":"Mona","family":"Lichtblau","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Pneumologie, Universit\u00e4tsspital Z\u00fcrich, Z\u00fcrich, Schweiz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satenik","family":"Harutyunova","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Pulmonale Hypertonie, Thoraxklinik am Universit\u00e4tsklinikum Heidelberg, Heidelberg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Klose","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Pneumologie, II. Medizinische Klinik und Poliklinik, Universit\u00e4tsklinikum Hamburg-Eppendorf, Hamburg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"von Bonin","sequence":"additional","affiliation":[{"name":"Uniklinikum Dresden, Medizinische Klinik I \u2013 Pneumologie, Dresden, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Bubeck","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Pulmonale Hypertonie, Thoraxklinik am Universit\u00e4tsklinikum Heidelberg, Heidelberg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekkehard","family":"Gr\u00fcnig","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Pulmonale Hypertonie, Thoraxklinik am Universit\u00e4tsklinikum Heidelberg, Heidelberg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Harbaum","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Pneumologie, II. Medizinische Klinik und Poliklinik, Universit\u00e4tsklinikum Hamburg-Eppendorf, Hamburg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Heberling","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Pneumologie, II. Medizinische Klinik und Poliklinik, Universit\u00e4tsklinikum Hamburg-Eppendorf, Hamburg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Heinrich","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin II, Universit\u00e4tsklinikum Regensburg, Regensburg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"L\u00f6ffler-Ragg","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Pneumologie, LKH Hochzirl-Natters, Natters, Medizinische Universit\u00e4t Innsbruck, Innsbruck, \u00d6sterreich"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Steringer-Mascherbauer","sequence":"additional","affiliation":[{"name":"Ordensklinikum Linz\/Elisabethinen, II Interne Abteilung, Kardiologie, Angiologie und Intensivmedizin, Linz, \u00d6sterreich"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Wenter","sequence":"additional","affiliation":[{"name":"Bezirkskrankenhaus Sterzing, Sterzing, S\u00fcdtirol, Italien"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Wick","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Pneumologie, Universit\u00e4tsspital Z\u00fcrich, Z\u00fcrich, Schweiz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn","family":"Wilkens","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Pneumologie und Beatmungsmedizin, Thoraxklinik am Universit\u00e4tsklinikum Heidelberg, Heidelberg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Xanthouli","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Pulmonale Hypertonie, Thoraxklinik am Universit\u00e4tsklinikum Heidelberg, Heidelberg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Pulmonale Hypertonie, Thoraxklinik am Universit\u00e4tsklinikum Heidelberg, Heidelberg, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2401129","DOI":"10.1183\/13993003.01129-2024","article-title":"Exploring the patient perspective in pulmonary hypertension","volume":"64","author":"H J Ford","year":"2024","journal-title":"Eur Respir J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2401325","DOI":"10.1183\/13993003.01325-2024","article-title":"Treatment algorithm for pulmonary arterial hypertension","volume":"64","author":"K M Chin","year":"2024","journal-title":"Eur Respir J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2401180","DOI":"10.1183\/13993003.01180-2024","article-title":"Management of pulmonary hypertension in special conditions","volume":"64","author":"I R Preston","year":"2024","journal-title":"Eur Respir J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1030693","DOI":"10.3389\/fphar.2022.1030693","article-title":"Adherence and treatment patterns of disease-specific drugs among patients with pulmonary arterial hypertension: A nationwide, new-user cohort study","volume":"13","author":"C Y Tsai","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40256-022-00553-6","article-title":"Adherence and Discontinuation of Disease-Specific Therapies for Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis","volume":"23","author":"S Qadus","year":"2023","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e026620","DOI":"10.1161\/JAHA.122.026620","article-title":"Association Between Copayment and Adherence to Medications for Pulmonary Arterial Hypertension","volume":"11","author":"E M Schikowski","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s41030-023-00244-w","article-title":"Comparative Treatment Persistence and Adherence to Endothelin Receptor Antagonists Among Patients with Pulmonary Arterial Hypertension in Japan: A Real-World Administrative Claims Database Study","volume":"9","author":"J Omura","year":"2023","journal-title":"Pulm Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.healun.2021.01.006","article-title":"Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE","volume":"40","author":"N H Kim","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1111\/bcp.14347","article-title":"Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects","volume":"86","author":"S Grill","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e00846","DOI":"10.1002\/prp2.846","article-title":"Bioequivalence and food effect of a fixed-dose combination of macitentan and tadalafil: Adaptive design in the COVID-19 pandemic","volume":"9","author":"D Csonka","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"ref11","first-page":"1219","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)","volume":"34","author":"N Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the Internat","volume":"30","author":"N Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e12173","DOI":"10.1002\/pul2.12173","article-title":"Nutritional status in pulmonary arterial hypertension","volume":"12","author":"C T Kwant","year":"2022","journal-title":"Pulm Circ"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e12425","DOI":"10.1002\/pul2.12425","article-title":"Carnitine consumption and effect of oral supplementation in human pulmonary arterial hypertension: A pilot study","volume":"14","author":"E L Brittain","year":"2024","journal-title":"Pulm Circ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-025-02682-9","article-title":"Right ventricular function in pulmonary hypertension and obesity \u2013 a cross-sectional cohort study with survival follow-up2024","author":"B Egenlauf","year":"2025","journal-title":"Clin Res Cardiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacc.2023.10.045","article-title":"Randomized Trial of Macitentan\/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension","volume":"83","author":"E Gr\u00fcnig","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e003023","DOI":"10.1136\/bmjresp-2024-003023","article-title":"Medication adherence and clinical outcome in patients with pulmonary arterial hypertension or distal chronic thromboembolic pulmonary hypertension","volume":"12","author":"L Reimann","year":"2025","journal-title":"BMJ Open Respiratory Research"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.healun.2012.08.010","article-title":"Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey","volume":"31","author":"K M Swetz","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1513\/AnnalsATS.202005-552RL","article-title":"Palliative Care Perception in Pulmonary Arterial Hypertension: Evaluating the Interaction of PPCI, PAH-SYMPACT Questionnaire, and the REVEAL 2.0 Risk Score","volume":"18","author":"M Hrustanovic-Kadic","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21693\/1933-088X-21.1.7","article-title":"Palliative Care and Pulmonary Arterial Hypertension","volume":"21","author":"L S Rhee","year":"2022","journal-title":"Advances in Pulmonary Hypertension"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e013844","DOI":"10.1161\/JAHA.119.013844","article-title":"Association Between Palliative Care and Death at Home in Adults With Heart Failure","volume":"9","author":"K L Quinn","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.113.004526","article-title":"Anticoagulation and Survival in Pulmonary Arterial Hypertension","volume":"129","author":"K M Olsson","year":"2014","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension","volume":"388","author":"M M Hoeper","year":"2023","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","article-title":"Sotatercept for the Treatment of Pulmonary Arterial Hypertension","volume":"384","author":"M Humbert","year":"2021","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.lfs.2012.02.018","article-title":"Endothelin receptor antagonist has limited access to the fetal compartment during chronic maternal administration late in pregnancy","volume":"91","author":"L G Thaete","year":"2012","journal-title":"Life Sci"},{"issue":"S 68","key":"ref26","first-page":"PA4302","article-title":"Fluid restriction in patients with pulmonary arterial hypertension and right heart failure","volume":"64","author":"B Egenlauf","year":"2024","journal-title":"Eur Respir J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/eurheartj\/ehx099","article-title":"Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial","volume":"38","author":"S Ulrich","year":"2017","journal-title":"Eur Heart J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"22038","DOI":"10.1038\/s41598-024-70650-w","article-title":"Long-term oxygen therapy in precapillary pulmonary hypertension \u2013 SOPHA study","volume":"14","author":"N Benjamin","year":"2024","journal-title":"Scientific Reports"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"130","author":"S Provencher","year":"2006","journal-title":"Gastroenterology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.chest.2024.10.051","article-title":"Effects of beta-Blockers on the Outcomes in Patients With Pulmonary Arterial Hypertension Stratified by the Presence of Comorbid Conditions: A Multicenter Prospective Cohort Study: The Database of Pulmonary Hypertension in the Polish Population (BNP-PL)","volume":"167","author":"M Waligora","year":"2025","journal-title":"Chest"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.120.052503","article-title":"Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure","volume":"143","author":"M E Nassif","year":"2021","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1055\/s-0045-1804805","article-title":"Effekt von SGLT2 Inhibitoren bei Patienten mit pulmonal-arterieller Hypertonie und kardialen Komorbidit\u00e4ten","volume":"79","author":"A Florea","year":"2025","journal-title":"Pneumologie"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41598-023-28608-x","article-title":"Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension","volume":"13","author":"P Xanthouli","year":"2023","journal-title":"Scientific Reports"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/ham.2009.10306","article-title":"Can patients with pulmonary hypertension travel to high altitude?","volume":"10","author":"A M Luks","year":"2009","journal-title":"High Alt Med Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1378\/chest.11-2016","article-title":"Effects of Commercial Air Travel on Patients With Pulmonary Hypertension","volume":"142","author":"N Roubinian","year":"2012","journal-title":"Chest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MAJ.0b013e31815f1e35","article-title":"Hypoxia During Air Travel in Adults With Pulmonary Disease","volume":"335","author":"L C Mohr","year":"2008","journal-title":"Am J Med Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/jcm11102769","article-title":"Cardiorespiratory Adaptation to Short-Term Exposure to Altitude vs. Normobaric Hypoxia in Patients with Pulmonary Hypertension","volume":"11","author":"S Schneider","year":"2022","journal-title":"J Clin Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e12397","DOI":"10.1002\/pul2.12397","article-title":"Air travel in patients suffering from pulmonary hypertension \u2013 A prospective, multicentre study","volume":"14","author":"A Yogeswaran","year":"2024","journal-title":"Pulm Circ"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/eurheartj\/ehad789","article-title":"Overnight exposure to high altitude in pulmonary hypertension: adverse events and effect of oxygen therapy","volume":"45","author":"S R Schneider","year":"2024","journal-title":"Eur Heart J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1513\/AnnalsATS.202412-1279OC","article-title":"Effect of an Overnight Stay at 2500 m on Nocturnal Hypoxemia and Sleep-disordered Breathing in Patients with Pulmonary Vascular Disease: A Randomized Trial","volume":"22","author":"M Lichtblau","year":"2025","journal-title":"Ann Am Thorac Soc"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1183\/09031936.00089212","article-title":"Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey","volume":"41","author":"S Meyer","year":"2013","journal-title":"Eur Respir J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1053\/j.jvca.2019.10.059","article-title":"Outcomes After Noncardiac Surgery for Patients with Pulmonary Hypertension: A Historical Cohort Study","volume":"34","author":"A Deljou","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jacc.2005.02.055","article-title":"Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality","volume":"45","author":"G Ramakrishna","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1161\/CIR.0000000000001136","article-title":"Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association","volume":"147","author":"S Rajagopal","year":"2023","journal-title":"Circulation"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.healun.2022.06.013","article-title":"ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery","volume":"41","author":"D P McGlothlin","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s12630-023-02520-4","article-title":"The perioperative use of inhaled prostacyclins in cardiac surgery: a systematic review and meta-analysis","volume":"70","author":"B Marcus","year":"2023","journal-title":"Can J Anaesth"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1377\/hlthaff.2017.0175","article-title":"Approximately One In Three US Adults Completes Any Type Of Advance Directive For End-Of-Life Care","volume":"36","author":"K N Yadav","year":"2017","journal-title":"Health Aff (Millwood)"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1200\/JCO.19.00013","article-title":"Understanding and Addressing the Role of Coping in Palliative Care for Patients With Advanced Cancer","volume":"38","author":"J A Greer","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2016.16840","article-title":"Association Between Palliative Care and Patient and Caregiver Outcomes: A Systematic Review and Meta-analysis","volume":"316","author":"D Kavalieratos","year":"2016","journal-title":"JAMA"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1089\/jpm.2013.0153","article-title":"Moving upstream: a review of the evidence of the impact of outpatient palliative care","volume":"16","author":"M Rabow","year":"2013","journal-title":"J Palliat Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S2213-2600(14)70226-7","article-title":"An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial","volume":"2","author":"I J Higginson","year":"2014","journal-title":"Lancet Respir Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment","volume":"318","author":"E Basch","year":"2017","journal-title":"JAMA"},{"key":"ref53","first-page":"15","article-title":"NewsCAP: National Coalition for Hospice and Palliative Care issues updated guidelines","volume":"119","author":"National Coalition for Hospice and Palliative Care","year":"2019","journal-title":"Am J Nurs"},{"key":"ref54","first-page":"572000124","article-title":"EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study","author":"R A Lewis","year":"2021","journal-title":"Eur Respir J"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(15)60901-1","article-title":"Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on planetary health","volume":"386","author":"S Whitmee","year":"2015","journal-title":"Lancet"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"N Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"ref57","volume-title":"Adherence to long-term therapies: evidence for action","author":"World Health Organization","year":"2003"},{"key":"ref58","first-page":"1828","article-title":"Extreme Heat and Cardiovascular Health: What a Cardiovascular Health Professional Should Know","volume":"37","author":"G K Chaseling","year":"2021","journal-title":"Can J Cardiol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(14)62114-0","article-title":"Mortality risk attributable to high and low ambient temperature: a multicountry observational study","volume":"386","author":"A Gasparrini","year":"2015","journal-title":"Lancet"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"M Humbert","year":"2022","journal-title":"Eur Heart J"}],"container-title":["Pneumologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2625-4859.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:42:54Z","timestamp":1759790574000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2625-4859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":60,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,6]]},"published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2625-4859","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0934-8387","1438-8790"],"issn-type":[{"value":"0934-8387","type":"print"},{"value":"1438-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}